Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02684045 · ClinicalTrials.gov registry record
Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine
A clinical trial, sponsored by Medtronic Spinal and Biologics.
- Completed
- Registry status
- 76
- Enrollment target
NCT02684045: Completed study, sponsored by Medtronic Spinal and Biologics.
NCT02684045 is a clinical trial that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02684045 has completed, sponsored by Medtronic Spinal and Biologics.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The purpose of this chart review is to assess outcomes in subjects that received MAGNIFUSE in the posterolateral lumbar spine at 1 or 2 continuous levels from L1-S1.
Primary Outcome
Fusion status will be assessed using the Lenke posterior fusion criteria below: * Grade I: Solid trabeculated transverse process and facet fusions bilaterally. * Grade II: Thick fusion mass on one side, and difficult to visualize on the other side. * Grade III: Suspected lucency or defect in the fusion mass. * Grade IV: Definite resorption of graft with fatigue of instrumentation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2017-08-15 |
What the finished NCT02684045 record still lists
NCT02684045 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02684045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02684045 about?
NCT02684045 is a clinical study titled "Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine". The purpose of this chart review is to assess outcomes in subjects that received MAGNIFUSE in the posterolateral lumbar spine at 1 or 2 continuous levels from L1-S1.
What is the current status of trial NCT02684045?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2017-03-01. Estimated completion is 2017-08-15.
Who is sponsoring clinical trial NCT02684045?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI